These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24856188)

  • 1. Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers.
    Stenman G; Persson F; Andersson MK
    Oral Oncol; 2014 Aug; 50(8):683-90. PubMed ID: 24856188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
    Stenman G
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker.
    Fonseca FP; Sena Filho M; Altemani A; Speight PM; Vargas PA
    J Oral Pathol Med; 2016 Feb; 45(2):101-10. PubMed ID: 25990369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical and molecular profile of salivary gland cancer in children.
    Locati LD; Collini P; Imbimbo M; Barisella M; Testi A; Licitra LF; Löning T; Tiemann K; Quattrone P; Bimbatti E; Chiaravalli S; Casanova M; Tamborini E; Carta R; Gasparini P; Guzzo M; Massimino M; Ferrari A
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28139061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The landscape of gene fusions and somatic mutations in salivary gland neoplasms - Implications for diagnosis and therapy.
    Andersson MK; Stenman G
    Oral Oncol; 2016 Jun; 57():63-9. PubMed ID: 27101980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors.
    Andersson MK; Åman P; Stenman G
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion oncogenes and tumor type specificity--insights from salivary gland tumors.
    Stenman G
    Semin Cancer Biol; 2005 Jun; 15(3):224-35. PubMed ID: 15826837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary gland cancers: biology and molecular targets for therapy.
    Bell D; Hanna EY
    Curr Oncol Rep; 2012 Apr; 14(2):166-74. PubMed ID: 22246609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary Gland Neoplasms: Does Morphological Diversity Reflect Tumor Heterogeneity.
    Rito M; Fonseca I
    Pathobiology; 2018; 85(1-2):85-95. PubMed ID: 28930752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation-associated salivary gland tumors: a review and update.
    Weinreb I
    Adv Anat Pathol; 2013 Nov; 20(6):367-77. PubMed ID: 24113307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
    Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary Gland Cancers: Biology and Systemic Therapy.
    Goyal G; Mehdi SA; Ganti AK
    Oncology (Williston Park); 2015 Oct; 29(10):773-80. PubMed ID: 26470903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics.
    von Holstein SL; Fehr A; Persson M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
    Ophthalmology; 2013 Oct; 120(10):2130-8. PubMed ID: 23725736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.
    Chen Z; Chen J; Gu Y; Hu C; Li JL; Lin S; Shen H; Cao C; Gao R; Li J; Ha PK; Kaye FJ; Griffin JD; Wu L
    Oncogene; 2014 Jul; 33(29):3869-77. PubMed ID: 23975434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoid cystic carcinoma: emerging role of translocations and gene fusions.
    Wysocki PT; Izumchenko E; Meir J; Ha PK; Sidransky D; Brait M
    Oncotarget; 2016 Oct; 7(40):66239-66254. PubMed ID: 27533466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of novel fusion genes by next-generation sequencing-based targeted RNA sequencing analysis in adenoid cystic carcinoma of head and neck.
    Shibata E; Morita KI; Kayamori K; Tange S; Shibata H; Harazono Y; Michi Y; Ikeda T; Harada H; Imoto I; Yoda T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Oct; 132(4):426-433. PubMed ID: 34413003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma.
    Fehr A; Kovács A; Löning T; Frierson H; van den Oord J; Stenman G
    J Pathol; 2011 Jul; 224(3):322-7. PubMed ID: 21618541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior.
    Tirado Y; Williams MD; Hanna EY; Kaye FJ; Batsakis JG; El-Naggar AK
    Genes Chromosomes Cancer; 2007 Jul; 46(7):708-15. PubMed ID: 17437281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary gland carcinoma: Towards a more personalised approach.
    Rached L; Saleh K; Casiraghi O; Even C
    Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma.
    Okumura Y; Miyabe S; Nakayama T; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
    Histopathology; 2011 Jul; 59(1):90-7. PubMed ID: 21668476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.